A ‘Lobby’ Where a Molecule Mob Tells Genes What to Do
By Philip Ball,
Quanta Magazine
| 02. 14. 2024
The discovery during the Human Genome Project in the early 2000s that we humans have only about 20,000 protein-coding genes — about as many as the tiny soil-dwelling nematode worm, and less than half as many as the rice plant — came as a shock. That blow to our pride was softened, though, by the idea that the human genome is rich in regulatory connections. Our genes interact in a dense network, in which pieces of DNA and the molecules they encode (RNA and proteins) control the “expression” of other genes, influencing whether they make their respective RNA and proteins. To understand the human genome, we needed to understand this process of gene regulation.
That task, however, is proving to be much harder than decoding the sequence of the genome.
Initially, it was suspected that gene regulation was a simple matter of one gene product acting as an on/off switch for another gene, in digital fashion. In the 1960s, the French biologists François Jacob and Jacques Monod first elucidated a gene regulatory process in mechanistic detail: In Escherichia coli bacteria...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...